A Study of LY3375880 in Healthy Participants

NCT03343587 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3375880 IV
DRUG: LY3375880 SC
DRUG: Placebo IV
DRUG: Placebo SC

Sponsor

Eli Lilly and Company